SABCS20 - Antibody drug conjugates in de oncologie

In dit interview bespreekt hoogleraar Moleculaire Immunologie Paul Parren, werkzaam bij het Leids Universitair Medisch Centrum en Lava Therapeutics, de verschillende aspecten van antibody drug conjugates (ADS’s) met internist-oncoloog prof. dr. ir. Koos van der Hoeven. Parren hield een voordracht over dit ondwerp tijdens het San Antonio Breast Cancer Symposium 2020.

Episode metadata supplied by the publisher feed · Published Dec 11, 2020

Embed this episode

Attribution link and audio player

Ready to play

SABCS20 - Antibody drug conjugates in de oncologie

0:00 28:03

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncologie.nu?

This episode is 28 minutes long.

When was this Oncologie.nu episode published?

This episode was published on December 11, 2020.

Can I download this Oncologie.nu episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!